CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-11 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Exercise or conversion | +130,000 | $5.40 | $701K | 2,470,684 |
| 2024-11-11 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Exercise or conversion · Stock Option (right to buy) | −130,000 | 78,496 | ||
| 2024-11-08 | Sheena Jonathan Director | Sale 10b5-1 | −360 | $129.78 | $47K | 282,112 |
| 2024-11-08 | Sheena Jonathan Director | Sale 10b5-1 | −2,171 | $130.89 | $284K | 279,941 |
| 2024-11-08 | Sheena Jonathan Director | Sale 10b5-1 | −169 | $131.85 | $22K | 279,772 |
| 2024-11-08 | Sheena Jonathan Director | Sale 10b5-1 | −736 | $130.40 | $96K | 56,696 |
| 2024-11-08 | Sheena Jonathan Director | Sale 10b5-1 | −764 | $131.14 | $100K | 55,932 |
| 2024-11-08 | Sheena Jonathan Director | Sale 10b5-1 | −998 | $130.47 | $130K | 56,434 |
| 2024-11-08 | Sheena Jonathan Director | Sale 10b5-1 | −412 | $131.24 | $54K | 56,022 |
| 2024-11-08 | Sheena Jonathan Director | Sale 10b5-1 | −90 | $131.84 | $12K | 55,932 |
| 2024-10-31 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,866 | $126.45 | $236K | 68,851 |
| 2024-10-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −754 | $119.93 | $90K | 70,717 |
| 2024-10-28 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,057 | $118.21 | $125K | 206,027 |
| 2024-10-28 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,196 | $118.21 | $141K | 110,695 |
| 2024-10-28 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −929 | $118.21 | $110K | 113,136 |
| 2024-10-28 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −3,960 | $118.21 | $468K | 189,762 |
| 2024-10-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,238 | $118.21 | $146K | 71,471 |
| 2024-10-25 | ROSENMAN HERM Director | Grant or award | +178 | 65,765 | ||
| 2024-10-25 | HEALY JAMES Director | Grant or award | +153 | 46,004 | ||
| 2024-10-25 | BOTHA ROELOF Director | Grant or award | +203 | 3,767 |
Page 64 of 85 · 1,682 trades